Functional Rescue of Dystrophin-deficient mdx Mice by a Chimeric Peptide-PMO

This publication has 37 references indexed in Scilit:

• Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
  Molecular Therapy, 2010
• Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
  The Lancet Neurology, 2009
• Octa-guanidine Morpholino Restores Dystrophin Expression in Cardiac and Skeletal Muscles and Ameliorates Pathology in Dystrophic mdx Mice
  Molecular Therapy, 2009
• Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
  Proceedings of the National Academy of Sciences, 2008
• Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice
  Molecular Therapy, 2008
• Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes inmdxMice
  Human Gene Therapy, 2008
• Cell-penetrating peptide–morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo
  Biochemical Society Transactions, 2007
• Antisense Oligonucleotide-induced Exon Skipping Across the Human Dystrophin Gene Transcript
  Molecular Therapy, 2007
• Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
  Nature Medicine, 2006
• Power Output of Fast and Slow Skeletal Muscles of MDX (Dystrophic) and Control Mice After Clenbuterol Treatment
  Experimental Physiology, 2000